We found that ADCY1 RS2293106 (C > A) had a significant effect on the response of platinum-based chemotherapy in NSCLC patients, and patients carrying the A allele had a better response to platinum-based chemotherapy than those carrying the G allele. The gene discussed is ADCY1; the disease is non-small cell lung carcinoma.